| Literature DB >> 32858946 |
Xin Yuan1, Shenqiang Hu1, Liang Li1, Hehe Liu1, Hua He1, Jiwen Wang1.
Abstract
Stearoyl-CoA desaturase (SCD) is known to be an important rate-limiting enzyme in the production of monounsaturated fatty acids (MUFAs). However, the role of this enzyme in goose follicular development is poorly understood. To investigate the metabolic mechanism of SCD during goose follicular development, we observed its expression patterns in vivo and in vitro using quantitative reverse-transcription (qRT)-PCR. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to determine a cellular model of SCD function in granulosa cells (GCs) via SCD overexpression and knockdown. qRT-PCR analysis showed that SCD was abundantly expressed in the GC layer, and was upregulated in preovulatory follicles. Peak expression was found in F1 and prehierarchal follicles with diameters of 4-6 mm and 8-10 mm, respectively. We further found that mRNA expression and corresponding enzyme activity occur in a time-dependent oscillation pattern in vitro, beginning on the first day of GC culture. By LC-MS/MS, we identified numerous changes in metabolite activation and developed an overview of multiple metabolic pathways, 10 of which were associated with lipid metabolism and enriched in both the overexpressed and knockdown groups. Finally, we confirmed cholesterol and pantothenol or pantothenate as potential metabolite biomarkers to study SCD-related lipid metabolism in goose GCs.Entities:
Keywords: SCD knockdown; SCD overexpression; Stearoyl-CoA; goose follicular development; granulosa cells; lipid metabolism
Mesh:
Substances:
Year: 2020 PMID: 32858946 PMCID: PMC7565484 DOI: 10.3390/genes11091001
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1(A) The goose ovary contains a hierarchy of large preovulatory follicles and a small cohort of prehierarchal follicles. (B) Relative expression level of Stearoyl-CoA desaturase (SCD) in granulosa layer and theca layer during follicle development in vivo. The data are represented as the mean ± SD (n = 3); the data were analyzed by ANOVA and Tukey’s test. The lowercase letters indicate significant differences between different granulosa cell (GC) layers and theca cell (TC) layers (p < 0.05).
Details of the sequences of siRNAs and primers for GFP-SCD.
| Name | Sense Sequence (5′-3′) | Antisense Sequence (5′-3′) |
|---|---|---|
| siRNA210 | GCGAUACGUCUGGAGGAAUTT | AUUCCUCCAGACGUAUCGCTT |
| siRNA405 | GCGGAUCUUCUUGACUAUUTT | AAUAGUCAAGAAGAUCCGCTT |
| siRNA774 | GCUCAACGCCACUUGGCUATT | UAGCCAAGUGGCGUUGAGCTT |
| siRNA-scrambled | UUCUCCGAACGUGUCACGUTT | ACGUGACACGUUCGGAGAATT |
| primers for GFP-SCD | CCGCTCGAGATGGAGAAGGACTTACTCAGTCATG | CCCAAGCTTTCAGCCGCTCTTGTGACTCCC |
Figure 2(A) Relative expression level of SCD in goose granulosa cells (GCs) cultured in vitro for 7 days. (B) SCD enzyme activity. The data are represented as the mean ± SD (n = 3); the data were analyzed by ANOVA and Tukey’s test. The lowercase letters indicate significant differences in cultured goose GCs for 7 days in vitro (p < 0.05).
Figure 3The detection of SCD transfection efficiency. (A) Overexpressed-transfected cells were collected at the indicated time points after transfection for qRT-PCR analyses. (B) siRNA-transfected cells were collected at the indicated time points after transfection for qRT-PCR analyses. The data are represented as the mean ± SD (n = 3); the data were analyzed by ANOVA and Tukey’s test. The lowercase letters indicate significant differences between experimental groups and control groups (p < 0.05).
Figure 4(A) Metabolic differences in GC cellular model is highlighted in the principal component analysis (PCA) score plot. The overexpressed SCD group is denoted S, the GFP group is denoted G, and the control group is denoted N; the siRNA-210 group is denoted T, the siRNA-470 group is denoted F, and the scrambled siRNA group is denoted C. For the PCA, the first component accounts for 25.24% of overall variability and the second component accounts for 18.66% of overall variability. (B) Orthogonal correction partial least squares discriminant analysis (OPLS-DA) of the metabolites from each group. PCA and OPLS-DA models demonstrating a separation between each group.
Figure 5(A) Heat map from the hierarchical clustering of differential metabolites in overexpressed SCD group and control group. (B) Heat map from the hierarchical clustering of differential metabolites in knockdown SCD group and control group. The scaled expression by row (metabolites) is shown as a heat map and is reordered by a hierarchical clustering analysis (Pearson’s distance and Ward’s method) on both rows and columns. Significant differential metabolites between overexpressed group and knockdown group were identified with cutoff values of a VIP > 1, FC > 1.2. The color scale indicates the relative amounts of metabolites: red, higher levels; green, lower levels; black, unchanged.
Figure 6Venn diagram of overlapping and unique metabolites altered in each group. A total of 22 metabolites were overlapping in the N vs. S and G vs. S comparisons. A total of 14 metabolites overlapped in the C vs. T and C vs. F comparisons (Table S2).
Figure 7Topology analysis of metabolic pathways identified in the GCs of goose overexpressed or knockdown SCD. N vs. S comparison (A), G vs. S comparison (B), C vs. T comparison (C), and C vs. F comparison (D). Advanced bubble chart shows the enrichment of differentially abundant metabolites in pathways. The x-axis represents the rich factor (rich factor = number of different metabolites enriched in the pathway/number of all metabolites in the background metabolites set). The y-axis represents the enriched pathways. Size of the bubble represents the number of different abundant metabolites enriched in the pathway, and the color represents enrichment significance.
Metabolic pathways and significantly different metabolites associated with lipid metabolism and enriched in both the overexpressed and the knockdown groups.
| Pathway | N vs. S | G vs. S | C vs. T | C vs. F | Lipid-Related Functions Reported | Reference |
|---|---|---|---|---|---|---|
| Steroid hormone biosynthesis/Steroid biosynthesis | Cholesterol | Cholesterol | Androsterone/Vitamin D3 | Androsterone | Steroid hormones are essential regulators of a vast number of physiological processes. | [ |
| Galactose metabolism | UDP-glucose | D-Sorbitol; Dulcitol | D-Glucose; D-Sorbitol | D-Glucose; Myoinositol | Galactose exerts primarily suppressive effects of ovarian follicle number and steroid secretion by direct actions on the ovary. | [ |
| Tryptophan metabolism | N-Acetyl-5-Hydroxytryptamine; Anthranilic acid | N-Acetyl-5-Hydroxytryptamine | Succinic Acid | Epinephrine | Molecular modeling studies suggested favorable stacking interactions between cholesterol and tryptophan, in which the face of the complex ring system of cholesterol and the indole ring of tryptophan build the interaction interface. | [ |
| Sulfur metabolism | L-Cysteine; 2-Aminoethanesulfonic Acid | 2-Aminoethanesulfonic Acid; L-Homoserine | Succinic Acid | L-Homoserine | Recently, increasing attention has been paid to the role of sulfur amino acids in regulating lipid metabolism. | [ |
| Cysteine and methionine metabolism | L-Cysteine; S-Sulfo-L-Cysteine; L-Alanine; Glutathione Reducedform; S-(5-Adenosy)-L-Homocysteine | L-Homoserine; L-Cystine | S-Sulfo-L-Cysteine | L-Homoserine; S-(5-Adenosy)-L-Homocysteine | Much attention has been recently focused on the effects of methionine restriction and cysteine on metabolic health, especially lipid metabolism. | [ |
| pyrimidine metabolism | Uridine 5-Monophosphate; UDP-glucose | Β-Pseudouridine | Cytidine; 2-Deoxyribose 1-Phosphate | 2-Deoxyribose 1-Phosphate | Given the link between pyrimidine metabolism and liver lipid accumulation, there is a potential for the use of nucleosides and nucleoside analogs in the treatment of fatty liver conditions. | [ |
| Pantothenate and CoA biosynthesis | Pantothenate; L-Cysteine | Pantothenol | Pantothenol | Pantothenol | Pantothenate forms the core of CoA and is a precursor to acyl carrier protein (ACP), making it essential in both energy and lipidmetabolism. | [ |
| Biosynthesis of amino acids | Anthranilic acid; Glycine; S-Sulfo-L-Cysteine; S-(5-Adenosy)-L-Homocysteine; L-Threonine; L-Alanine; L-Cysteine; L-Ornithine; L-Isoleucine | L-Ornithine; L-Homoserine; L-Threonine; Shikimic Acid | S-Sulfo-L-Cysteine | L-Homoserine; Glycine; L-Asparagine Anhydrous; S-(5-Adenosy)-L-Homocysteine | Amino acids were distributed in a lipid bilayer. | [ |
| ABC transporters | 2-Aminoethanesulfonic Acid; Spermidine; proline betaine; Glycine; Betaine; Glutathione Reducedform; L-Ornithine; L-Isoleucine; Biotin; Choline; L-Threonine; L-Alanine; Inosine | Betaine; D-Sorbitol; Inosine; L-Cystine; L-Threonine; L-Ornithine; D-Mannitol; Spermidine; Guanosine; proline betaine; 2-Aminoethanesulfonic Acid; Xanthosine | D-Sorbitol; Xanthosine; Glycerol 3-phosphate; D-Glucose; Cytidine | Biotin; Myoinositol; Spermidine; Glycerol 3-phosphate; Glycine; Inosine; Guanosine; D-Glucose | ATP binding cassette (ABC) transporter proteins are thought to facilitate the ATP-dependent translocation of lipids or lipid-related compounds—such substrates include cholesterol, plant sterols, bile acids, phospholipids and sphingolipids. | [ |
| Neuroactive ligand-receptor interaction | 2-Aminoethanesulfonic Acid; L-Thyroxine; Glycine | 2-Aminoethanesulfonic Acid; Norepinephrine | Adenosine 5′-Diphosphate | Adenosine 5′-Diphosphate; Epinephrine; Glycine | Modulation of neurotransmitter receptors by lipids occurs at multiple levels, affecting a wide variety of activities, including their trafficking, sorting, stability, residence lifetime at the cell surface, endocytosis, and recycling, among other important functional properties at the synapse. | [ |
siRNA: small interfering RNA.
Figure 8Potential metabolic pathway in goose GCs induced by overexpressed and knockdown SCD. Notes: “↑” and “↓” in red indicate metabolites which are upregulated in the overexpressed SCD group and are downregulated in the control group, respectively; “↑” and “↓” in blue indicate metabolites which are upregulated in the knockdown SCD group and downregulated in the control group. All MS/MS spectra of those important metabolites are shown in Figure S3.